Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Compa...

FDA Recall #D-0773-2021 — Class II — August 19, 2021

Recall #D-0773-2021 Date: August 19, 2021 Classification: Class II Status: Terminated

Product Description

Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

Reason for Recall

Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.

Recalling Firm

Eli Lilly & Company — Indianapolis, IN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

119,539 4-packs

Distribution

USA Nationwide

Code Information

Lot number: D396436C

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated